Parameswaren Venugopal, MD
In the field of hematologic cancers, treatments nowadays are mostly targeted. Agents target the surface of cancer cells and kill them without damaging the neighboring, normal good cells. It’s a blessing to see the changes that have occurred in this field, where I can provide much better treatment options to patients.
Rush University: 1620 W Harrison St, Chicago, IL 60612, USA